23 March 2019 in International Journal of Basic & Clinical Pharmacology
Evaluation of antiulcer activity of ethanolic leaf extract of Coccinia grandis in indomethacin induced gastric ulcer model
15 February 2019 in Asian Journal of Pharmaceutical and Clinical Research
Objective: The objective of the study was to evaluate the hypolipidemic activity of fruit rind extracts of Garcinia gummi-gutta in diet-induced hyperlipidemic rats. Methods: Hydroalcoholic extract of fruit rinds of G. gummi-gutta was prepared using Soxhlet apparatus. 30 Wistar albino rats were divided into five groups (n=6). Except for Group 1, all the other groups were treated with hyperlipidemic diet (HLD) for 4 weeks. After induction, the Groups 3 and 4 were treated with the extracts at 100 mg/kg and 200 mg/kg doses, respectively, whereas Group 5 received the standard drug atorvastatin at 10 mg/kg for the next 4 weeks. Lipid profile was estimated at the end of each week. At the end of the study, rats were sacrificed and the liver and heart were analyzed for histopathological changes. Data expressed as mean±standard error of the mean. Statistical analysis was done using one-way ANOVA followed by post hoc Tukey test. p<0.05 considered statistically significant. Results: The serum levels of total cholesterol (TC), triglycerides (TG), very low-density lipoprotein (VLDL), and LDL were significantly increased and the levels of high-density lipoprotein (HDL) were significantly decreased when compared to normal control. The groups which received G. gummi-gutta rind extract at 100 mg/kg and 200 mg/kg showed a significant decrease in the mean cholesterol, TG, LDL, VLDL levels, and an increase in HDL levels when compared to the HLD group. The group which received the extract at higher dose (REGG200) was found better than the lower dose (REGG 100). REGG 200 showed significant improvement in increasing the HDL levels than all the test groups. The standard drug atorvastatin was found better than REGG100 but there was no significant difference between high doses of the extract and atorvastatin. Conclusion: The fruit rinds extract of G. gummi-gutta was able to decrease the elevated serum lipids (TC, TG, LDL, and VLDL) and consequently increase the HDL levels in a dose-dependent manner.
30 December 2020 in Biomedical and Pharmacology Journal
Objective: To evaluate the Hypolipidemic& Antioxidant effect of Garcinia gummi-gutta barks on Atherogenic Diet-Induced Hyperlipidemic Rats. Materials and methods: Bark extract was prepared using a Soxhlet apparatus. 30 Wistar albino rats of either sex was divided into 5 groups (n=6). Atherogenic diet (AD) was administered to all the rats except group 1 for 4 weeks. Following induction, Group 3 & 4 were treated with bark extracts at 100 & 200mg/kg respectively and group 5 with atorvastatin at 10mg/kg for the next 4 weeks along with AD. Weekly estimation of lipid profile was done and, in the end, all the animals were sacrificed and the liver and heart were sent for histopathological examination. MDA levels were estimated by measuring the TBARS activity. Results were expressed in the Mean ± standard error of the mean. Statistical analysis was done using one-way ANOVA followed by post hocTukey test. p<0.05 is considered statistically significant. Result: There was a significant decrease in the mean cholesterol, triglyceride, low-density lipoproteins&very-low-density lipoproteins and an increase in High-density lipoproteins when compared to the AD group. Barks extracts at both doses (100mg/kg & 200mg/kg) showed a significant reduction in lipid profile wherein the extract at higher dose was found to be better and there was no significant difference when compared to atorvastatin. Conclusion: The study showed that bark extract of Garcinia gummi-guttapossess significant hypolipidemic & antioxidant activity. Further studies are warranted for its clinical use in humans.
23 May 2019 in International Journal of Basic & Clinical Pharmacology
Background: The current study was done to evaluate the effect of hydro alcoholic extract of Salacia oblonga on aluminum induced toxicity in brain cortex and blood in Wistar albino rats.Methods: The experimental animals were divided into four groups, each group comprising of six animals for 36 days of experimental duration. We investigated Na+/K+, Mg2+, Ca2+ ATPases enzyme activity in brain cortex and hematological changes if any, upon administration of aluminum chloride (Alcl3) (300 mg/kg b.w), hydro alcoholic extract of Salacia oblonga (67 mg/kg b.w) and Alcl3+ Salacia oblanga with control (distilled water).Results: In brain cortex, Salacia caused an increased in activity of ATPases. Combined administration of Salacia suppressed the influence of aluminum on the ATPases in the brain cortex (p<0.05). Both aluminum as well as Salacia did not cause any alteration in the hemoglobin content of blood in Wistar albino rats. The erythrocytes count was also not altered by treatment with either aluminum or Salacia. Combined treatment with Salacia suppressed the influence of aluminum with reference to neutrophil count and significant increases in monocyte as well as lymphocyte count were seen. Thus, repeated administration of aluminum causes a decrease in neutrophil and increase in lymphocyte count.Conclusions: All the ATPases in brain cortex were found to be affected by aluminum administration and Salacia is found to counteract the ATPase effect to a particular extent implying the presence of an active principle that can counteract the aluminium toxicity indicating its possible usefulness in aluminum toxicity.
1 January 2017 in International Journal of Basic & Clinical Pharmacology
12 May 2026 in Journal of Complementary and Integrative Medicine
Objectives: In this study, the hydroalcoholic extract of entire Begonia malabarica plant was screened to identify its specific phytochemical groups and in vitro cytotoxic potential against HepG2 (Human Hepatocellular carcinoma) cell lines. Methods: Annexin V/PI Apoptotic assay and the MTT assay, were employed in this study. MTT assay was used to evaluate in vitro cytotoxic potential of B. malabarica extract against the HepG2 cell line. The Annexin V/PI Apoptotic assay was performed to estimate the proportion of cells undergoing apoptosis. The results were compared with doxorubicin as standard. Results: The MTT assay found that at highest concentration of 500 μg/mL, the hydroalcoholic extract of B. malabarica reduced cell viability to 24.17 %, while doxorubicin treated cell showed cell viability to 4.8 % at highest concentration of 100 μg/mL. Flow cytometry based Annexin V analysis revealed that B. malabarica extract induced pronounced apoptosis in HepG2 cells, marked by a dominant late apoptotic population (70.56 %) and dead cells (22.17 %), with minimal early apoptotic (0.04 %) and viable cells (7.23 %). The percentage of cells undergone late apoptosis was identical to standard drug doxorubicin (71.2 %). These results suggest a late apoptotic response, potentially involving mitochondrial disruption, oxidative stress, or caspase activation. Conclusions: These findings highlight the presence of bioactive compounds in B. malabarica that can modulate cell death pathways, supporting its potential as a potential anti-cancer agent. However, more research can help in better understanding of the role of this plant as a potential new source of cancer therapy and uncover previously unknown pharmacological activities and properties.